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ABSTRACT
Objectives To describe national trends in bariatric surgery
and examine the factors influencing outcome in bariatric
surgery in England.
Design Observational population cohort study.
Setting Hospital Episode Statistics database.
Participants All patients who had primary gastric bypass,
gastric banding, or sleeve gastrectomy procedures
between April 2000 and March 2008.
Main outcome measures 30 day mortality, mortality at
one year after surgery, unplanned readmission to
hospitalwithin 28 days, and duration of stay in hospital.
Results 6953 primary bariatric procedures were carried
out during the study period, of which 3649 were gastric
band procedures, 3191 were gastric bypass procedures,
and 113 were sleeve gastrectomy procedures. A marked
increase occurred in the numbers of bariatric procedures
done, from 238 in 2000 to 2543 in 2007, with an increase
in the percentage of laparoscopic procedures over the
study period (28% (66/238) laparoscopic procedures in
2000 compared with 74.5% (1894/2543) in 2007).
Overall, 0.3% (19/6953) patients died within 30 days of
surgery. The median length of stay in hospital was 3
(interquartile range 2-6) days. An unplanned readmission
to hospital within 28 days of surgery occurred in 8% (556/
6953) of procedures. No significant increase in mortality
or unplanned readmission was seen over the study
period, despite the exponential increase in minimal
access surgery and consequently bariatric surgery.
Conclusions Bariatric surgery has increased
exponentially in England. Although postoperative weight
loss and reoperation rates were not evaluated in this
observational population cohort study, patients selected
for gastric banding had lower postoperative mortality and
readmission rates and a shorter length of stay than did
those selected for gastric bypass.
INTRODUCTION
Obesity is a global concern. The World Health Orga-
nization predicts that by 2015, 700 million of the
world’s population will be obese, as defined by a
body mass index of at least 30 (calculated as weight
(kg)/height(m)2).1
Basedon surgical techniques originating in the 1950s,
bariatric surgery has developed considerably and has
increased in popularity in recent years.2 Procedures
have traditionally beendescribed as being either restric-
tive ormalabsortive,3 but a greater understanding of the
pathophysiology of obesity, including the role of gut
hormones, has showed this to be a rather simplistic
view of the various procedures.4 Use ofminimally inva-
sive techniques has increased significantly in recent
years and is now recognised as standard practice in
most Western countries.2 5
Health consequences attributed to obesity are well
documented and involve physical, psychological, and
social consequences.1 6 After bariatric surgery, patients
have been shown to have an improvement or a com-
plete resolution of their comorbidities.7 Bariatric sur-
gery has been shown to reduce the risk of death,
hospital admission, and long term cost to the health
service.8-10 In the United Kingdom, the National Insti-
tute for Health and Clinical Excellence (NICE) pub-
lished guidance on the use of bariatric surgery in
2002.11 Morbid obesity was defined as a body mass
index exceeding 40 or a body mass index of 35 or
greater with significant coexisting disease that could
be improved by weight loss. A systematic review has
concluded that surgery is superior to conventional
treatment in reducing weight. However, the review
failed to show the superiority of one surgical method
over the others.12
Ells and colleagues investigated the demographics
of patients who had bariatric surgery in England
between 1996 and 2005.13 They identified significant
variation in the regional provision of this service. Lit-
tle is known about the trends and demographics of
bariatric surgery in England in more recent years.
The aim of this study was to investigate national
trends in the contemporary use of bariatric surgery
in England. In particular, we sought to describe the
use of different surgical techniques, as well as the
uptake of laparoscopic surgery, and to examine the
factors influencing postoperative outcome after baria-
tric surgery.
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METHODS
Hospital Episode Statistics
TheHospital Episode Statistics (HES) dataset has been
described previously.14 In brief, this dataset is nation-
ally collected and incorporates all admissions to NHS
trusts in England (a trust may comprise more than one
hospital site). Patients treated in non-NHShospitals are
not included in this dataset. During the period of this
study, no national database included all bariatric
patients in the independent sector and theNHS inEng-
land. HES data include diagnostic, procedural, and
demographic information.The finished consultant epi-
sode represents the time a patient spends under the
care of a specialist or other allied health professional.
These episodes may be linked into a single admission.
A patient is assigned a primary diagnosis code and up
to 13 secondary diagnoses codes by using the ICD-10
(international classification of diseases, 10th revision).
Up to 12 procedural codes are assigned by using the
Office of Population Censuses and Surveys Classifica-
tion of Surgical Operations and Procedures, 4th edi-
tion (OPCS-4.4, introduced in 2007). Earlier editions
of OPCS were used for admissions before the OPCS-
4.4 was introduced. Data on patients’ death after
admission is available through a link between the
HES database and the Office of National Statistics.15
The Carstairs index is used to measure socio-
economic deprivation. This is based on a patient’s
postcode and specifically uses four variables: unem-
ployment, overcrowding, car ownership, and social
class. Comorbidity is measured with the Charlson
comorbidity index, which was originally validated
against mortality.16
Inclusions
We included in the study all adult patients who had a
primary elective bariatric procedure (gastric bypass,
gastric banding, or sleeve gastrectomy) with a primary
diagnosis of obesity between April 2000 and March
2008. We used the following ICD-10 diagnosis codes
to denote obesity: E66.0—obesity due to excess cal-
ories, E66.1—drug induced obesity, E66.2—extreme
obesity and hypoventilation, E66.8—other obesity,
and E66.9—obesity unspecified.
We used OPCS-4 codes to select those patients who
had a primary bariatric procedurewith a primary diag-
nosis of obesity.Weused separate codes to define three
types of bariatric surgery: gastric bypass, sleeve gas-
trectomy, and gastric banding (table 1). A separate
code for sleeve gastrectomy was introduced in OPCS
4.3 (April 2006). We used laparoscopic codes (Y508—
other specified approach through abdominal cavity,
Y75—minimal access approach to abdominal cavity)
to differentiate laparoscopic from open procedures.
We did not include other bariatric procedures such as
biliopancreatic diversion because of disparate coding
for these procedures.
We divided patients into three age groups:
17-40 years, 41-60 years, and older than 60 years.
The Carstairs deprivation index allowed us to classify
patients into five groups (1-5, in order of increasing
socioeconomic deprivation; category 6 denotes
patients with noCarstairs index recorded).Wedivided
patients into two groups on the basis of their Charlson
comorbidity index: those with a score of 0-2 and those
scoring greater than 2.
Outcome measures
We defined readmission as an unplanned admission
within 28 days of discharge after the primary bariatric
procedure. We studied predictors of in-hospital mor-
tality at 30 days and totalmortality at 365days.Data on
deaths at 365 days were available from April 2000 to
March 2005, so we did not include patients admitted
after March 2005 in the analysis of 365 day mortality.
Length of stay refers to the number of nights spent in
hospital on the primary admission.
Provider volume
We defined providers as NHS trusts doing primary
bariatric procedures from 2000 to 2007. We ranked
patients into equal thirds of provider volume, giving
low volume, medium volume, and high volume
groups, according to the total caseload during the
study period. We therefore considered provider
volume as a categorical variable. This approach has
been used previously in other outcome studies that
have considered volume in the absence of a priori
data.17-20
Statistical methods
We used SPSS 17.0 for statistical analyses. We consid-
ered P values <0.05 to be significant. We used χ2 ana-
lyses to investigate categorical variables. We
investigated continuous variables that were normally
distributed by using the t test and analysis of variance.
We analysed non-parametric data by using Mann-
Whitney, Kruskal-Wallis, and Spearman’s tests. We
usedmultiple logistic regression analyses to investigate
independent predictors of readmission within 28 days
and 30 day mortality. We included in the multiple
regression analysis those variables that showed a
level of significance of P<0.1. We logarithmically
transformed data on length of stay before the regres-
sion analysis.
RESULTS
Between April 2000 andMarch 2008, 6953 adults had
a primary elective bariatric procedure. Of these, 3191
patients had gastric bypass, 3649 had a gastric banding
Table 1 | ICD-10 (international classification of diseases, 10th revision) codes used to define
three types of bariatric surgery
Primary bariatric procedure ICD-10 codes
Gastric bypass G281, G282, G283, G288, G289, G311, G312, G313, G314, G315,
G316, G318, G319, G310, G320, G321, G322, G323, G324, G325,
G328, G329, G330,G331, G332, G333, G335, G336, G338, G339
Sleeve gastrectomy* G285
Gastric banding G301, G302, G303, G304, G308, G309
*G285 was introduced in April 2006.
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procedure, and 113 patients had a sleeve gastrectomy.
The code for sleeve gastrectomy was introduced in
April 2006.
During the study period, 85 providers carried out
between 1 and 604 procedures each; 154 consultant
surgeons did between 1 and 552 procedures each
over the study period. We divided NHS hospitals
into thirds according to their total caseload over the
eight year study period. After ranking patients accord-
ing to the total volume of procedures carried out by
their provider, we considered a low volume provider
to be a hospital trust that did 188 procedures or fewer
and a high volume provider to be a trust that did more
than 384 procedures over the study period.We consid-
ered the remaining trusts to be medium volume provi-
ders. Table 2 shows the characteristics of the patients
who had bariatric surgery.
Trends over time
Patients’ mean age at surgery increased slightly over
time from 40 (SD 9.39) years to 43 (9.97) years
(P<0.001).We found amarked increase in the number
of bariatric procedures carried out during the study
period from 238 in 2000-1 to 2543 to 2007-8 (figure).
The figure shows changing trends in the use of open
and laparoscopic procedures, with a substantial
increase in the use of laparoscopy over time. In 2000,
28% (66/238) of bariatric procedures were done lapar-
oscopically. By 2007, 74.5% (1894/2543) of proce-
dures were laparoscopic.
Mortality outcomes
Overall, 30 day postoperative mortality was 0.3% (19/
6953). Between April 2000 and March 2005 (that is,
when 365 day postoperative mortality data were avail-
able), one year mortality was 1.3% (24/1866). Table 3
shows the 30 day and 365 day mortality, readmission
rate, and length of stay by operation. As the sleeve gas-
trectomy code was introduced in 2006, the 365 day
mortality is not available for these patients.
The risk of postoperative mortality was higher
among patients with comorbidity (Charlson score >2,
8% (2/26) v Charlson score ≤2, 0.2% (17/6927);
P=0.002). Patients from areas of higher social depriva-
tion had higher 365 day mortality (Carstairs 5 (most
deprived) 3% (15/495) v Carstairs 1 (least deprived)
1% (3/239); P=0.004). This association was not evident
for 30 day mortality (P=0.219).
Thirty daymortalitywas lower after laparoscopic sur-
gery comparedwithopen surgery (laparoscopic surgery
0.2% (7/4436) v open surgery 0.5% (12/2517);
P=0.014). Table 4 shows the characteristics and out-
comes of patients who had laparoscopic and open bar-
iatric procedures. Sex and age were not associated with
either 30 day mortality (sex P=0.841; age P=0.900) or
365 day mortality (sex P=0.122; age P=0.693).
We found no variation over the study period in post-
operative mortality (P=0.618), mortality at one year
(P=0.614), or readmissions (P=0.817).Operation type
and comorbidity score were predictors of postoperative
mortality inmultiple logistic regressionanalysis (table 5).
28 day unplanned readmission and length of stay
The overall median length of stay was 3 (interquartile
range 2-6) days, and the readmission rate was 8%
Table 2 | Patients’ characteristics by type of operation. Values are numbers (percentages) unless stated otherwise
Characteristic Gastric bypass Gastric banding Sleeve gastrectomy Total P value*
Total number 3191 (45.9) 3649 (52.5) 113 (2) 6953 (100)
Mean (SD) age (years) 42.25 (9.50) 42.44 (9.79) 44.18 (8.96) 42.38 (9.65) 0.364
Female sex 2571 (80.6) 2968 (81.3) 76 (67) 5615 (80.8) 0.001
Comorbidity score:
Charlson score ≤2 3179 (99.6) 3637 (99.7) 111 (98) 6927 (99.6)
0.047
Charlson score >2 12 (0.4) 12 (0.3) 2 (2) 26 (0.4)
Carstairs index of social deprivation:
1 (least deprived) 352 (11.0) 459 (12.6) 6 (5) 817 (11.8)
0.011
2 480 (15.0) 607 (16.6) 13 (12) 1100 (15.8)
3 580 (18.2) 675 (18.5) 23 (20) 1278 (18.4)
4 797 (25.0) 878 (24.1) 28 (25) 1703 (24.5)
5 (most deprived) 975 (30.6) 1026 (28.1) 42 (37) 2043 (29.4)
Unclassified 7 (0.2) 12 (0.3) 1 (1) 12 (0.2)
Laparoscopy rate 1579 (49.5) 2768 (75.9) 89 (79) 4436 (63.8) <0.001
*Analysis of variance of three operative procedures (gastric bypass, gastric banding, and sleeve gastrectomy).
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(556/6953). Women were less likely than men to be
readmitted within 28 days (women 7.7% (430/5615) v
men 9.4% (126/1338); P=0.033). Patients who had
sleeve gastrectomy were readmitted more often than
were other patients (P<0.001), as shown in table 3.
Medium volume trusts tended to readmit patients less
often thandid other trusts (lowvolume8.6% (212/2479)
vmediumvolume 6.9% (164/2365) v high volume 8.5%
(180/2109); P=0.064). Patients who had laparoscopic
surgery were less likely to be readmitted than were
those who had open procedures (laparoscopic 6.6%
(291/4436) v open 10.5% (265/2517); P<0.001). The
28 day readmission rate did not increase over time
(P=0.817). Type of operation and open technique were
independent predictors of readmission (table 5).
The extent of comorbidity was a significant predic-
tor of hospital stay (Charlson score ≤2, 3 (interquartile
range 2-6) days (n=6927) v Charlson score >2, 5 (3-8)
days (n=26); P=0.039).Women had a shorter length of
stay than didmen (women 3 (2-6) days (n=5615) vmen
4 (1-6) days (n=1338); P=0.017). Length of in-hospital
stay decreased significantly over the study period (rela-
tive risk 0.89, 95% confidence interval 0.88 to 0.89;
P<0.001). Patients who had laparoscopic surgery had
a significantly shorter length of stay than did thosewho
had an open procedure (laparoscopic 2 (4-8) days
(n=4436) v open 6 (1-4) days (n=2517); P<0.001).
Patients treated inmediumvolume trusts had the short-
est length of stay (low volume 4 (2-6) days (n=2365) v
medium volume 3 (1-5) days (n=2365) v high volume 4
(2-6) days (n=2109); P<0.001).
On multiple linear regression analysis, sex, type
of operation, laparoscopic approach, age, comorbid
status, social deprivation, and trust and consultant
volume were predictors of length of stay (table 6).
Gastric bypass versus gastric banding
Gastric banding and gastric bypass are the two most
prevalent bariatric procedures in England; gastric
bypass procedures increased as a proportion of the
Table 3 | Outcome by type of operation. Values are numbers (percentages) unless stated otherwise
Outcome
Gastric bypass
(n=3191)
Gastric banding
(n=3649)
Sleeve gastrectomy
(n=113)
Total
(n=6953) P value*
30 day mortality 15 (0.5) 3 (0.1) 1 (1) 19 (0.3) 0.004
365 day mortality 13/786 (1.7) 11/1080 (1.0) NA 24/1866 (1.3) 0.229
28 day readmission rate 308 (9.7) 232 (6.4) 16 (14) 556 (8.0) <0.001
Median (interquartile range) length of stay (days) 5 (3-7) 2 (1-3) 4 (3-7) 3 (2-6) <0.001
*Analysis of variance of three operative procedures (gastric bypass, gastric banding, and sleeve gastrectomy) for 30 day mortality, 365 day mortality, and 28 day readmission; Kruskal Wallis
of three operative procedures for length of stay.
Table 4 | Patients’ characteristics and outcomes after gastric bypass and gastric banding surgery, and for all patients who had laparoscopic and open
surgery. Values are numbers (percentages) unless stated otherwise
Gastric bypass
(n=3191)
Gastric banding
(n=3649) P value
Open approach
(n=2517)
Laparoscopic approach
(n=4436) P value
Mean (SD) (95% CI) age (years) 42.25 (9.50)
(41.92 to 42.58)
42.44 (9.79)
(42.13 to 42.76)
0.413 42.23 (9.51)
(41.86 to 42.60)
42.47 (9.72)
(42.19 to 42.76)
0.308
Female sex 2571 (80.6) 2968 (81.3) 0.420 2023 (80.4) 3592 (81.0) 0.542
Comorbidity score:
Charlson score ≤2 3179 (99.6) 3637 (99.7)
0.742
2502 (99.4) 4422 (99.7)
0.290
Charlson score >2 12 (0.4) 12 (0.3) 12 (0.5) 14 (0.3)
Carstairs index of social deprivation:
1 (least deprived) 352 (11.0) 459 (12.6)
0.041
276 (11.0) 541 (12.2)
0.056
2 480 (15.0) 607 (16.6) 374 (14.9) 726 (16.4)
3 580 (18.2) 675 (18.5) 457 (18.2) 821 (18.5)
4 797 (25.0) 878 (24.1) 654 (26.0) 1049 (23.6)
5 (most deprived) 975 (30.6) 1026 (28.1) 749 (29.8) 1294 (29.2)
Unclassified 7 (0.2) 12 (0.3) 7 (0.3) 5 (0.1)
Laparoscopy rate 1579 (49.5) 2768 (75.9) 0.001 NA NA NA
Provider volume:
Low (1-188 procedures) 971/2423 (40.1) 1452/2423 (59.9)
<0.001
884/2479 (35.7) 1595/2479 (64.3)
<0.001Medium (189-384 procedures) 782/2338 (33.4) 1556/2338 (66.6) 699/2365 (29.6) 1666/2365 (70.4)
High (>384 procedures) 1438/2079 (69.2) 641/2079 (30.8) 934/2109 (44.3) 1175/2109 (55.7)
30 day mortality 15/3191 (0.5) 3/3649 (0.1) 0.002 12/2517 (0.5) 7/4436 (0.2) 0.014
365 day mortality* 13/786 (1.7) 11/1080 (1.0) 0.229 17/1047 (1.6) 7/812 (0.9) 0.143
28 day readmission rate 308/3191 (9.7) 232/3649 (6.4) <0.001 265/2517 (10.5) 291/4436 (6.6) <0.001
Median (interquartile range) lengthof stay (days) 5 (3-7) 2 (1-3) <0.001 6 (4-8) 2 (1-4) <0.001
NA=not applicable.
*Available from April 2000 to March 2005.
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total number of procedures over the study period
(2000: gastric bypass 27% (65/238), gastric banding
73% (173/238); 2007: gastric bypass 47.7% (1212/
2543), gastric banding 49.2% (1251/2543); P<0.001).
Therefore, we examined gastric bypass and gastric
banding separately. Use of the laparoscopic approach
was greater among patients who had gastric banding
compared with those who had gastric bypass (gastric
banding 75.9% (2768/3649) v gastric bypass 49.5%
(1579/3191); P<0.001). Furthermore, hospital stay in
patientswhohad a bypass procedurewas greater (med-
ian length of stay: 5 (3-7) days (n=3191) for gastric
bypass v 2 (1-3) days (n=3649) for gastric banding;
P<0.001) and readmission rates postoperatively were
higher (28 day readmission: 9.7% (308/3191) for
gastric bypass v 6.4% (232/3649) for gastric banding;
P<0.001). The risk of postoperative (30 day
in-hospital) mortality was lower for patients who had
laparoscopic banding than for those who had laparo-
scopic bypass (odds ratio 0.10, 95%confidence interval
0.01 to 0.79; P=0.029).
DISCUSSION
This population based observational study included
6953 patients who had primary bariatric surgery over
an eight year period. This is the first study to analyse
national outcomes after surgery for obesity in England.
Over the study period, we saw an exponential increase
in the volume of bariatric surgery being carried out. By
2007, largely equivalent volumes of gastric bypass and
gastric banding procedures were being done. Women
and patients from more socially deprived areas were
more likely than men and patients from more affluent
areas to havebariatric surgery inNHShospitals. Patients
with higher comorbidities and those frommore socially
deprived areas showed poorer peri-operative outcome
than did other patients. Over the study period, an
exponential increase in use of minimal access bariatric
surgery occurred. The availability of the laparoscopic
approachhasbeenaccompaniedbya lower readmission
rate and shorter duration of inpatient stay.
Over the later part of the studyperiod, the number of
bariatric procedures carried out seems to have
increased sharply (figure). The reasons for the rapid
expansion in provision of bariatric surgery in recent
years are manifold. The NICE guideline, advocating
the use of surgery for obesity, was published in
2002.11 An anticipated delay in changes to everyday
practice regularly follows the implementation of such
a guideline, given the requirement for training and
expansion of services. In addition, agreement must
be sought from primary care trusts (the main commis-
sioners in theNHS) that obesity surgerywill be funded.
In conjunction with the growing level of obesity, as
patients become more aware of surgery as a viable
treatment option, demand for surgery among mor-
bidly obese patients increases. The expansion of baria-
tric surgery will begin to tackle the unmet need for
bariatric surgery.
As the use of laparoscopy has increased, so have the
absolute numbers of bariatric procedures.Aswith other
procedures, a learning curve is associated with bariatric
surgery.21 In this study, despite the relatively low num-
bers of procedures done by individual surgeons and
providers, we saw no increase in either readmission or
mortality rates over the study period, suggesting that
laparoscopy has been introduced in a safe manner into
the NHS. Indeed, laparoscopy was associated with
improved outcome as measured in this study.
Banding versus bypass
Gastric banding was the most common operation in
patients having primary bariatric surgery in England.
This study showed a lower readmission rate at 28 days,
Table 5 | Multiple logistic regression analysis of 30 day mortality and 28 day readmission, including all patients
Cofactor
30 day mortality 28 day readmission
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Age (years): * 0.142
17-40 1.00
41-60 1.08 (0.90 to 1.28) 0.426
>60 0.52 (0.24 to 1.11) 0.091
Operation type: 0.049 <0.001
Gastric bypass 1.00 1.00
Gastric banding 0.22 (0.06 to 0.77) 0.018 0.71 (0.59 to 0.87) 0.001
Sleeve gastrectomy 1.60 (0.18 to 13.78) 0.672 1.69 (0.98 to2.93) 0.061
Female vmale sex * 0.81 (0.66 to 1.01) 0.055
Comorbidity:
Charlson score ≤2 1.00 *
Charlson >2 27.26 (5.53 to 134.49) <0.001
Laparoscopy vs open surgery 0.49 (0.19 to 1.30) 0.153 0.65 (0.54 to 0.78) 0.001
Provider volume: * 0.256
Low (1-188 procedures) 1.00
Medium (189-384 procedures) 0.84 (0.68 to 1.05) 0.120
High (>384 procedures) 0.88 (0.71 to 1.09) 0.246
*Only covariates for which P>0.1 on univariate analyses were included in multiple regression model.
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reduced 30 day and 365 day mortality, and a shorter
length of stay after gastric banding compared with gas-
tric bypass and sleeve gastrectomy, although we did
not compare postoperative weight loss, morbidity, or
revision rates. These findings agree with those of a
recent prospective randomised study, in which gastric
banding performed more favourably than gastric
bypass in terms of mortality at one year and readmis-
sion within 30 days.22 Lancaster and Hunter found
similar results in an observational study using Ameri-
can College of Surgeons National Surgical Quality
Improvement Program (ACS-NSQIP) data from the
United States.23 The NSQIP study also reported a
reduced 30 day complication rate among patients hav-
ing laparoscopic gastric banding compared with
laparoscopic gastric bypass.
However,mortality, readmission rates, and lengthof
stay are not the predominant outcome measures of
interest to bariatric surgeons. Importantly, gastric
bypass has been shown to be superior in terms of per-
centage postoperative weight loss.24 Furthermore,
patients selected for gastric bypass may have higher
body mass index than those selected for banding.
This may explain some of the differences in outcome
seen between banding and bypass patients. Clinical
registry data will be useful to assess other outcomes
from bariatric surgery, such as weight loss and post-
operative complications. In the United Kingdom, the
National Bariatric Surgery Registry (NBSR) has
recently been launched. This registrywill be important
in continuing to assess the safety as well as the efficacy
of bariatric surgery. In our study, the increase in gastric
bypass procedures outstripped that of gastric banding
between 2000 and 2008. This trend is diametrically
opposed to that in the United States, where gastric
banding has increased at a faster rate than bypass.2 25
The reasons for these opposing trends are unclear.
The US Food and Drug Administration first approved
laparoscopic adjustable gastric bands in 2001. In con-
trast, England and Europe have a longer history of
experience with gastric banding. This historical differ-
ence in practice may explain the increasing preference
in Europe for bypass, as European surgeons became
aware early of the disadvantages of banding. Although
banding may be technically less challenging to learn
and carry out, the increased weight loss seen after
bypass may be an additional driver of the increasing
preference in Europe for gastric bypass.
Patient related factors
The predominance of female patients having bariatric
surgery seen in this study has been observed in other
studies. Psychological factors, such as reduced self
esteem and greater rates of depression in female
patients, have been reported previously.26 Male
patients on the other hand may seek bariatric surgery
Table 6 | Multiple regression analysis for log transformed length of stay including all patients, with institutional volume and
surgeons’ volume considered separately*
Cofactor
Trust volume model Surgeon volume model
Relative risk (95% CI) P value Relative risk (95% CI) P value
Female sex (compared with male) 0.95 (0.92 to 0.99) 0.007 0.95 (0.92 to 0.99) 0.005
Operation:
Gastric bypass (reference)*
Gastric banding 0.48 (0.46 to 0.49) <0.001 0.48 (0.46 to 0.49) <0.001
Sleeve gastrectomy 1.19 (1.07 to 1.34) 0.002 1.15 (1.03 to 1.29) 0.012
Laparoscopic v open approach 0.76 (0.62 to 0.66) <0.001 0.63 (0.61 to 0.65) <0.001
Age cohort (years):
17-39 (reference)*
40-59 1.04 (1.04 to 1.11) <0.001 1.07 (1.04 to 1.11) <0.001
>59 1.02 (1.02 to 1.22) 0.022 1.11 (1.01 to 1.22) 0.025
Comorbidity score:
Charlson score ≤2 (reference)*
Charlson score >2 1.41 (1.12 to 1.79) 0.004 1.40 (1.11 to 1.77) 0.004
Fifth of deprivation (Carstairs index)
1 (least deprived) (reference)*
2 1.05 (1.00 to 1.11) 0.074 1.05 (1.00 to 1.11) 0.059
3 1.10 (1.04 to 1.16) 0.001 1.10 (1.04 to 1.16) 0.001
4 1.14 (1.08 to 1.20) <0.001 1.13 (1.08 to 1.19) <0.001
5 (most deprived) 1.15 (1.10 to 1.21) <0.001 1.13 (1.08 to 1.19) <0.001
6 (unclassified) 0.94 (0.67 to 1.32) 0.730 0.92 (0.66 to 1.29) 0.634
Discharge year 0.89 (0.89 to 0.90) <0.001 0.90 (0.90 to 0.91) <0.001
Trust volume/consultant volume:
Low (reference)*
Medium 0.87 (0.84 to 0.90) <0.001 0.80 (0.77 to 0.83) <0.001
High 0.77 (0.74 to 0.79) <0.001 0.73 (0.70 to 0.76) <0.001
*Length of stay has been logarithmically transformed and exponentiated after analysis.
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only when comorbidities become advanced or in the
presence of more extreme body mass index.27
Although most sleeve gastrectomy patients were also
female, we found a greater proportion of male patients
(49%) in this group than with other types of surgery.
Hamoui and colleagues noted a similar proportion of
male patients having sleeve gastrectomy.28 The pre-
ponderance of men in the sleeve gastrectomy group
may be explained by this procedure being used more
often in patients at higher surgical risk and men possi-
bly presenting with higher body mass index.
Our study shows an inverse relation between socio-
economic status and bariatric surgery (table 1); more
patients who had bariatric surgery in NHS hospitals
were from areas of lower social deprivation. A higher
prevalence of obesity or more extreme body mass
index in people from more deprived backgrounds
may account for this. The percentage of patients from
more affluent backgrounds, however, increased over
the study period, whichmay be a result of the inclusion
of patients from the independent sector treated inNHS
hospitals or of greater increases in rates of obesity over
time in the least deprived groups. No national dataset
includes all bariatric patients in the NHS and indepen-
dent sectors. Private patients treated in the indepen-
dent sector are not included in the Hospital Episode
Statistics dataset. Hence the actual number of more
affluent patients having bariatric surgery in England
is likely to have been under-represented in this
national study.
Variation between institutions
We found a wide variation in the number of proce-
dures carried out by different institutions over the
study period. The definition of high volume provider
used in this study differed from that used by the Amer-
ican College of Surgeons.29 In our study, we defined a
highvolume institution as anNHS trust that carriedout
more than 384 procedures over the study period. The
AmericanCollege of Surgeons defines high volume by
centre, with a number of operations exceeding 125 a
year needed to qualify as a level 1a/1b centre.29 In our
study, only 8/85 (9.4%) providersmet this definition in
2005.Medium volume providers had a lower readmis-
sion rate at 28 days and a shorter length of stay com-
pared with low and high volume providers, although
the differences in readmission were not statistically
significant after regression analyses. However, higher
volume centres did more gastric bypass procedures.
Complex patients are likely to be referred to tertiary
centres for surgery. These tertiary referral centres, with
more specialised expertise, are likely to be higher
volume centres. Differences in the case mix or com-
plexity of patients not accounted for in this study may
explain the variation in readmission rates and length of
stay between high andmedium volume centres. Use of
scoring systems such as the obesity surgery mortality
risk score may allowmore meaningful comparisons to
be drawn between centres operating on patients with
different levels of risk.30
We considered volume as a categorical variable in
this study. This method is similar to that used for other
studies looking at volume.17 31 We defined the thresh-
olds before analysis by using a statistical approach,
thereby attempting to negate the bias of selecting
thresholds that reach significance. Some researchers
have handled volume as a continuous variable.32 The
output, when a continuous approach is used, is difficult
to interpret in a manner that is clinically meaningful.
Study limitations
The disadvantages of routinely collected datasets have
been described elsewhere.14 33 34 However, HES data
have been used previously to assess the uptake in bar-
iatric surgery in the early years.13
HES data are limited in the outcome measures that
are available. From this dataset, we could draw no com-
parisons between procedures in terms of postoperative
weight loss, reoperation rate, resolution of comorbid-
ities, or health related quality of life. However, in
terms of documenting the national safety of bariatric
procedures, mortality, unplanned readmission, and
length of stay are important outcome measures.
In this study, we compared gastric bypass, gastric
banding, and sleeve gastrectomy. The specific code
for sleeve gastrectomy was introduced only in 2006,
limiting the numbers of sleeve gastrectomy proce-
dures. We excluded complex bariatric procedures
such as biliopancreatic diversion from this study. As
such, this study may have underestimated the morbid-
ity associated with bariatric surgery.
Conclusion
Use of bariatric surgery has increased exponentially in
England in recent years. This seems to have occurred
safely despite a large increase in uptake of minimal
access techniques. Although postoperative weight
loss and reoperation rate were not evaluated in this
observational population cohort study, patients
selected for gastric banding had lower postoperative
mortality, readmission rates, and a shorter length of
stay than those selected for gastric bypass.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Obesity is an increasing problem
NICE recommends bariatric surgery for morbidly obese patients and overweight patients with
coexisting disease who could benefit from weight loss
WHAT THIS STUDY ADDS
Laparoscopic bariatric surgery has increased exponentially in England, with no increase in
mortality or unplanned readmission between 2000 and 2008
Laparoscopic bariatric surgery seems to have been introduced into the English NHS in a safe
manner
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